Free Trial
OTCMKTS:AJINY

Ajinomoto 8/4/2025 Earnings Report

Ajinomoto logo
$27.08 -0.50 (-1.82%)
As of 03:58 PM Eastern

Ajinomoto EPS Results

Actual EPS
$0.23
Consensus EPS
$0.21
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

Ajinomoto Revenue Results

Actual Revenue
$2.47 billion
Expected Revenue
$2.69 billion
Beat/Miss
Missed by -$217.48 million
YoY Revenue Growth
N/A

Ajinomoto Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Ajinomoto's next earnings date is estimated for Wednesday, November 5, 2025, based on past reporting schedules.

Conference Call Resources

Ajinomoto Earnings Headlines

Ajinomoto Co. (OTCMKTS:AJINY) Short Interest Up 36.2% in July
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
Ajinomoto Co., Inc. Reports Q1 2025 Earnings
Ajinomoto Co. Reports Mixed Q1 2025 Results
See More Ajinomoto Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ajinomoto? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ajinomoto and other key companies, straight to your email.

About Ajinomoto

Ajinomoto (OTCMKTS:AJINY) Co., Inc. is a Tokyo-based global food and chemical corporation best known for pioneering the production of monosodium glutamate (MSG) as a flavor enhancer. Founded in 1909 by chemist Kikunae Ikeda, the company has grown into a diversified enterprise with two core business segments: Foods and Amino Science. Its Foods segment offers a wide array of products, including seasonings, processed frozen foods, ready-to-eat meals, and culinary sauces, catering both to retail consumers and foodservice operators.

In its Amino Science division, Ajinomoto leverages advanced biotechnology to produce amino acids, pharmaceuticals and specialty chemicals. The company develops and manufactures amino acids for use in food fortification, clinical nutrition and animal feed, as well as specialty chemicals for industrial applications. This segment underscores Ajinomoto’s commitment to innovation in health, nutrition and sustainable biochemical solutions.

With a presence in more than 130 countries, Ajinomoto has established a strong global footprint across Asia, the Americas, Europe and Africa. The company operates manufacturing facilities, research laboratories and sales offices worldwide, enabling it to tailor products to regional tastes and dietary needs. Ajinomoto also engages in collaborative research with academic and industry partners to advance food science and amino acid technology.

Under the leadership of President and CEO Mitsuhiro Ito, Ajinomoto continues to pursue a sustainability-focused management strategy. The company has set medium-term goals aimed at reducing environmental impact, enhancing nutritional outcomes and fostering social well-being. Through its longstanding expertise in umami and amino acid science, Ajinomoto strives to address global challenges in nutrition, health and resource efficiency.

View Ajinomoto Profile

More Earnings Resources from MarketBeat